Table 1.
Demographic and clinical characteristics of the three groups under study.
| Clinical Characteristics | No Myocardial Injury n = 1100 | TnI 0.1–1 µg/L n = 563 |
TnI ≥ 1 µg/L n = 191 |
p-Value |
|---|---|---|---|---|
| Mean age (SD) | 84.4 ± 6.1 | 84.67 ± 7.1 | 83.66 ± 6.4 | 0.527 |
| Male | 323 (29%) | 167 (29%) | 84 (43%) | 0.0004 |
| Atrial fibrillation | 142 (12.9%) | 109 (16%) | 52 (28%) | <0.0001 |
| Creatinine clearance <30 mL/min | 162 (14%) | 86 (15%) | 41 (21%) | 0.0506 |
| Coronary disease | 131 (12%) | 121 (21%) | 93 (48%) | <0.0001 |
| Heart failure | 92 (8%) | 71 (12%) | 37 (19%) | <0.0001 |
| Oral anticoagulant treatment | 116 (10%) | 82 (14%) | 40 (22%) | <0.0001 |
| History of cancer | 153 (14%) | 106 (18%) | 34 (17%) | 0.1240 |
| Cognitive impairment | 265 (24%) | 126 (23%) | 52 (27%) | 0.3795 |
SD = standard deviation.